Tagged with regulation

Pharma The Head of the Department of Medical Oncology at the Pitié-Salpêtrière Hospital reveals how France is the only country in the world with universal and unlimited access to healthcare, how the oncology world in France is committed to changing the perception of cancer and why the only way to prevent…

pharma The director of MRA Regulatory Consultants, Henriette Vienings reveals the important role they play in helping pharmaceutical companies navigate South Africa’s regulatory environment, as well as the importance of the technological advancements in the sector. She also illustrates the various success factors that have allowed MRA Regulatory Consultants to remain…

Pharma Frank Grosveld, Professor of Molecular Biology at Erasmus Medical Center, tells PharmaBoardroom about how Dutch research and development environment has evolved over recent decades.  Frank, to begin could you please introduce yourself to our readers around the world, with reference to your current research interests and educational responsibilities? I am…

Pharma Yves Bur reveals how the motivation behind his political engagement has been to raise awareness around the importance of improving the social security system. Bur also explains why having a real public health policy is another way of combatting the increase in health spending, and how France needs to reach…

Pharma Skanska Puerto Rico’s Ramon Navia discusses the challenges the sector has faced in recent years and how Skanska has adapted its services portfolio to better cater to local clients’ needs. Skanska provides world-class construction management services to the life science industry.  What differentiates Skanska from other competitors and makes the group the…

Holland In a market under strong pressures to contain costs, launching innovative products in a crowded market can be a challenge. Novo Nordisk GM Sanne Groenemeijer believes his organization’s willingness to try various solutions has helped them to maintain their dominant position as the market leader in diabetes. Since you took…

government PharmaBoardroom met the Secretary General of the Thai FDA and the Senior Expert on Pharmaceutical Standards at the FDA. They explained the FDA’s role in Thailand’s pharma market, what the organization is doing for Thai copyright rights, how it is promoting international investment and integration within the ASEAN Economic Community. Please introduce…

healthcare In the past, the Moroccan pharmaceutical sector primarily served local needs. Now it is ramping up its research and development capabilities, looking outwards to global markets, developing partnerships with other African countries, and beginning to think about social programs such as public access to healthcare. “[Morocco’s] success grew from a…

regulation Sevi Firat, Founding Partner of Firat Izgi discusses the legal challenges facing pharmaceutical companies looking to penetrate the healthcare market in Turkey, the evolution of the legal landscape and her expectations for the industry’s future. With pricing and regulations as the major challenges facing players within the Turkish pharma and…

Steri-Tech Steri-Tech is one of the few local contract sterilization service providers available in Puerto Rico. Jorge and Andy Vivoni, president and business development manager, discuss how they ensure that pharmaceutical companies continue to establish themselves in Puerto Rico. What is the strategic importance of Steri-Tech within the Puerto Rican life sciences…

medical devices The industry of medical devices is soaring in Mexico. The general manager of ConvaTec discusses strategic priorities, new approaches and how reduced time to market is feeding the double-digit growth of the company The last time we met you was back in 2012. What kept you busy over the past…

government Ana Ríus became the Secretary of Health of Puerto Rico in 2013 following a very dynamic career as Head of the Puerto Rico Health Medical Services Administration. She discusses the current changes being made in the country’s health system and how Medicare Advantage funding is critical to maintaining a stable…